Arcus Capital Partners’s Abbott ABT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-7,393
Closed -$926K 123
2025
Q4
$926K Buy
+7,393
New +$942K 0.33% 50
2023
Q1
Sell
-321
Closed -$35.2K 119
2022
Q4
$35.2K Buy
+321
New +$33.2K 0.01% 197

Other funds holding ABT

Arcus Capital Partners's ABT Position: Q1 2026 in Review

Arcus Capital Partners sold out of Abbott (ABT) in Q1 2026, closing a stake of 7,393 shares — an estimated $926K sold.

Arcus Capital Partners first reported a position in ABT in Q4 2022 and held it in 2 quarters. The position peaked at $926K in Q4 2025. 3,106 funds tracked by Wall St. Rank hold ABT as of Q1 2026.

  • Arcus Capital Partners reported no remaining Abbott position as of Q1 2026 after selling out during the quarter.
  • Arcus Capital Partners sold 7,393 Abbott shares in Q1 2026, an estimated $926K.
  • Arcus Capital Partners first reported a position in Abbott in Q4 2022 and held it in 2 quarters.
  • Arcus Capital Partners's Abbott position peaked at $926K in Q4 2025.
  • 3,106 funds tracked by Wall St. Rank held Abbott as of Q1 2026.

Based on Arcus Capital Partners's 13F filing for Q1 2026, filed 6 May 2026.